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Background: Adult-type abnormal origin of coronary artery from pulmo-
nary artery (ACAPA) is uncommon compared to infant-form which usually
induces extended myocardial necrosis and severe heart failure. The adult-type
form results in mild and rare symptoms, but it can cause myocardial ischemia
and sudden cardiac death at childhood and adult age. The objective of this
study was to describe the mode of presentation, cardiovascular imaging
methods for diagnosis and outcomes of patients diagnosed with adult-type
ACAPA.
Material and methods: The Patient Congenital Heart Disease database
was reviewed to identify all patients diagnosed with ACAPA and/or who had
surgical repair beyond the first year of life.
Results: From March 1976 to July 2011, 13 patients were identified with
adult-type ACAPA, at the age of 6 months to 64 years: 9 with left coronary
artery from pulmonary artery (ALCAPA) and 4 with right coronary artery
from pulmonary artery (ARCAPA). Cardiac symptoms initiated investigation
in 9 patients and a murmur in 4. Nine were diagnosed by transthoracic echo-
cardiography, 4 by coronary artery angiography and 1 by cardiac computed
tomography. Myocardial ischemia was detected preoperatively in 6 patients
with ALCAPA (66.7%) and 1 with ARCAPA (25%). Ten patients underwent
surgical implantation of the ACAPA into the ascending aorta. All were
asymptomatic after repair except one who required a second surgery at 7.9
years follow-up.
Conclusions: Adult-type ACAPA can be assessed by non invasive cardio-
vascular imaging. Direct aortic implantation is a reliable and effective to
establish dual coronary artery circulation and prevent risks due to myocardial
ischemia.
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This study was to assess the influence of anti-PHT medications on clinical
and echocardiographic parameters in children.
Methods: Patients <18 years diagnosed with primitive PHT were retro-
spectively reviewed. Functional class, RV and LV diameters, tricuspid regur-
gitation grade, systolic and mean pulmonary pressure, TAPSE and TAC were
recorded before and after anti-PHT treatment. Deceased or transplanted
patients (group I) were compared to survivors (group II).
Results: 16 patients (11 males), were diagnosed with PHT (11 primitive
and 5 illegitime association: closed VSD = 2, closed PDA = 2, TGA = 1), at
mean age of 6.7 years (0.7 to 16.2). All received anti-PHT treatment: mono-
therapy (IV prostacycline = 4, bosentan = 2), or bitherapy (IV prostacycline
+ bosentan = 2, bosentan + sildenafil = 7) or tritherapy (IV prostacycline
+ bosentan + sildenafi l = 1). Mean FU was 4.3 years (0.7 to 10.5). Five
patients died, 1 underwent heart-lung transplantation (group I = 6) at mean FU
3.4y (1 to 4.1), and 10 survived (group II) at mean FU 4.7y (0.8 to 9.5).
NYHA class changed from 50% class II, 37.5% III and 12.5% IV before
treatment, to 50% class I, 12.5% II and 37.5% IV after.
Overall mean RV/LV did not change (1 to 0.95). RV/LV decreased in
group II: 1.14 to 0.51, and increased in group I: 0.87 to 1.57. The proportion
of TR grade 0-I increased from 47% to 60%, and of TR grade II-III decreased
from 53% to 40%. All patients with TR grade III at end FU ranged in group I.
Systolic and mean pulmonary pressure did not change: respectively 92.1 to
99.9mmHg and 65.8 to 56.2mmHg, and were similar between groups I and II.
TAPSE and TAC were not available in group I, and increased in group II:
respectively from 14 to 17.9 mm and 76.8 to 101.6 ms.
All patients in group I were either in NYHA class IV at first presentation
(2cases), or received first therapy more than 6 months after diagnosis (4cases).
Conclusion: Anti-PHT therapy contributes to ameliorate functional class
and RV function despite no significant effect on pulmonary pressure level.
Persistent TR grade III and increasing RV/LV seem to be factors of bad prog-
nosis.
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Syncope in Wolff-Parkinson-White syndrome (WPW) may reveal an
arrhythmic event, but also can be without relationships with WPW. Vagal-
related syncope represents the most frequent cause of syncope in population.
Electrophysiologic study (EPS) is recommended to evaluate the cause of syn-
cope. The purpose of the study was to evaluate the influence of the age of the
patient on the causes of syncope.
Methods: 97 patients, 51 males, 46 females, mean age 35±17, with WPW
were admitted for unexplained dizziness and/or syncope; they had no other
heart disease and no documented arrhythmias. EPS consisted of atrial pacing
and programmed atrial stimulation using 1 and 2 extrastimuli in control state
and after isoproterenol.
Results: 29 patients were aged from 9 to 19 years (mean 15±1.4)(children
and teenagers/group I). 44 were aged from 20 to 49 years (mean 34±8)
(adults/group II). 24 were aged from 50 to 70 years (mean 60±8) (elderly/
group III). A potentially malignant form (rapid conduction in accessory
pathway (AP) >240 bpm in control state or >300 bpm after isoproterenol and
atrial fibrillation or antidromic tachycardia induction) was noted in 10 group I
patients (34%) more frequently than in group II patients (5/44) (11%) (p <0.017)
and III (0/24) (0%)(p<0.001). Differences between group II and III were not
significant (0.08). Orthodromic reentrant tachycardia was induced in 10 group
I patients (34%), 20 group II patients (45%) (NS) and 15 group III patients
(62.5%)(p<0.04) compared to group I. No tachycardia was induced in 9 group
I patients (31%), 19 group II patients (43%)(NS) and 9 group III patients
(37.5%)(NS).
Conclusion: Syncope in WPW syndrome frequently is directly related to
the prexcitation. The cause can be a reentrant tachycardia complicated by a
vagal reaction or a rapid atrial fibrillation or tachycardia. The malignant forms
as a cause of syncope were frequently noted in children and teenagers, rarely
in adults and never in elderly. The management of syncope in children and
teenagers with a preexcitation syndrome requires urgently an electrophysio-
logic study.
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Introduction: Transient elastography is a rapid, noninvasive and reproduc-
ible approach to assess liver fibrosis by measuring liver stiffness (LS). How-
ever, because the liver is enveloped by a capsule, any variation in
parenchymal fluid content could theoretically affect LS. LS has been corre-
lated to central venous pressure (CVP) in an animal model. We aimed to
determine the correlation between LS and CVP in children and adults with
congenital heart disease.
Methods: In this ongoing prospective study, all patients referred for right
heart catheterization were included. Measurements of mean right atrial pres-
sure were obtained under general anesthesia (Fi02=21%) using an Optitorque
5 French catheter. The patients underwent 10 LS measurements (median value
taken as representive) by transient elastography (Fibroscanâ, Echosens,
France) within the 24 hours before catheterization. The results of LS are
expressed in kilopascals (kPa).
Results: Eleven children (mean age=8±6 yo, 54% male) and 6 adults
(mean age=34±17 yo, 66% male) have been included so far. Catheterism indi-
cations were pulmonary angioplasty (n=5), Melody valve implantation (n=1),
fenestration occlusion after a Fontan procedure (n=1) and pre operative asses-
sement of a complex congenital heart defect (n=10). Mean right atrial pressure
was 9,1±3,9 mmHg and mean LS was 8,4±4,2 kPa. Correlation between LS
and mean right atrial pressure was excellent for these first 17 patients (r=0,87).
Conclusion: Liver stiffness is a new, rapid and reliable method to evaluate
CVP in patients with congenital heart disease. This non invasive parameter
could potentially be usefull for patients in whom CVP play a key role, espe-
cially in patients with a Fontan circulation.
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Introduction: The use of COAGUCHEK XS® (Roche Diagnostics), an
INR home measuring device, was authorised by the French Health High
Authority on June 2008 for children. Nevertheless, there are few data on
safety and effectiveness of patients self management particularly in children.
Methods: Since 2008, 23 children (mean age: 9 y; 16 males, 7 females)
and their families were trained to INR self testing and self management of
vitamin K antagonists (VKA) (acenocoumarol: n=10, fluindione : n=9, war-
farin: n=4). INR controls (self testing or lab) were made at expected dates
established by the french law. Additional measurements were authorised in
risky situations (illness, hyperthermia, forgetting VKA treatment, bleeding,
etc…). Drug dose adaptation was made either by the family or by the health
team if needed.
Objectives: To evaluate safety and efficacy in families performing self
management in our centre. Time in therapeutic range (TTR), severe haemor-
rhage (needing hospitalization and/or blood transfusion) and thrombosis recur-
rence were observed.
Results: Mean follow-up time was 529 days [1.5 y; range 0.3-2.5y]. Mean
TTR was 68.53% and was 90.14% when tolerance range was applied. There
was no severe haemorrhage or thrombosis recurrence during follow-up and
INR >5 were 0.5% (8/1604 measurements). Lastly, 3.5% additional measure-
ments were performed by the families.
Conclusion: VKA self management using COAGUCHEK XS® was safe
and effective in our centre. Clinical studies with larger sample and cost-effec-
tiveness considerations are required.
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The objective of this study was to report experience with levosimendan in
hemodynamically compromised children.
Material and methods: all patients aged < 18years with severe myo-
cardial dysfunction and dependent on inotrope support, who received levosi-
mendan infusion, were reviewed for clinical, biological and echocardiographic
(LV diameters, shortening fraction, sub-aortic Velocity Time Integral) data.
Levosimendan was administered as a continuous intravenous infusion over
24 hours, starting 0.1 micrograms per kg per mn and increased up to
0.2micrograms per kg per mn. Blood pressure and heart rate were continu-
ously monitored, ECG and Echocardiography recorded before, 3 and 5 days
after starting levosimendan.
Results: From 2007 to 2011, 8 patients aged 3.5 months to 13years (mean
41months) received 10 courses of levosimendan. All were on milrinone sup-
port (mean dose 0.63 mcg/kg/mn) and 3 on associated dobutamine. All
achieved the 24-hour course of levosimendan without any complication. Cat-
echolamines were successfully discontinued in 5 cases (3 weaned off at 24th
hour and 2 at 5th day). Average milrinone dose dropped to 0.3 mcg/kg/mn at
day-5, p=0.028). mean shortening fraction increased from 10.8%±1.8 before
to 12.7± 2.3 at day-3 (p= 0.67), mean Velocity Time Integral from 6±0.6 to
8.7±1.2 cm at day-3 (p= 0.04). 
Five patients (62.5%) were successfully discharged from CICU: 2 are
doing well at 1 and 4.5 years follow-up, 1 died from metabolic disease and
2 were readmitted at 1.5 – and 2-month interval and received a second course
of levosimendan. The latter 2 patients did not improve and needed mechanical
ventricular assistance (1 died and 1 underwent successful heart transplanta-
tion). For the remaining 3 patients, first course levosimendan failed and heart
transplantation was performed in an emergency setting (pretransplant mechan-
ical ventricular support in 2).
Conclusion: This small size sample study shows encouraging results of
levosimendan in children with uncontrolled myocardial dysfunction. Further
studies are needed to assess monitoring, timing and indications for repeated
dose infusion during follow-up.
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Background: Congenital heart defects are often diagnosed in infancy, or
even before birth. But some anomalies are harder to detect than others and
may not be diagnosed until much later in childhood or even adulthood. In
developing countries many congenital heart diseases are detected in adult-
hood.
Objective: The aim of this study was to investigate the epidemiology, clin-
ical aspects, diagnosis and treatment of congenital heart disease screened at
adulthood.
Methods: This is a retrospective cohort by medical records analysis
enrolled between January 2010 and March 2012 in one center. We investi-
gated patients with congenital heart diseases aged over 16 years. All patients
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